Discover 525 paid clinical trials in Hershey, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 525
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
for
Head and Neck Squamous Cell Carcinoma
Location: York PA, Baltimore MD, Philadelphia PA, New York NY,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT06163534
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
for
Triple-Negative Breast Cancer
Location: York PA, Newark DE, Philadelphia PA, Silver Spring MD,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06393374
Phase3, Recruiting
GEMINI-NSCLC: NSCLC Biomarker Study
for
Non-Small Cell Lung Cancer
Location: York PA, Baltimore MD, Frederick MD, Bethesda MD,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT05236114
Recruiting
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Location: York PA, Bethesda MD, Columbus OH, Maumee OH,
Sponsor: Tempus AI
Sex: All
Age: 0+
Code: NCT07154823
Recruiting
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
for
CLL, Chronic Lymphocytic Leukemia
Location: York PA, Bethesda MD, New York NY, Westbury NY,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06846671
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
for
Breast Neoplasms
Location: York PA, Newark DE, Winchester VA, New Brunswick NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07060807
Phase3, Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for
Lymphoma, Large B-Cell, Diffuse
Location: York PA, Newark DE, Sellersville PA, Philadelphia PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06890884
Phase2, Recruiting
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
for
CRC (Colorectal Cancer)
Location: York PA, Baltimore MD, Doylestown PA, Bethesda MD,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07284849
Phase3, Recruiting
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: York PA, Bethesda MD, Hampton VA, Boston MA, Barrie,
Sponsor: Loxo Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06588478
Phase2, Recruiting
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
for
Small Cell Lung Cancer
Location: York PA, Baltimore MD, Chapel Hill NC, Columbus OH,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT05257551
Recruiting
CtDNA Based MRD Testing for NAC Monitoring in TNBC
for
TNBC - Triple-Negative Breast Cancer, Minimal Residual Disease
Location: York PA, Washington DC DC, Stony Brook NY, Ypsilanti MI,
Sponsor: Personalis Inc.
Sex: Female
Age: 18+
Code: NCT06230185
Recruiting
Prospective Global Registry for the Study of Chronic Total Occlusion Intervention
for
Coronary Artery Disease
Location: York PA, Brooklyn NY, New York NY, Pittsburgh PA,
Sponsor: Minneapolis Heart Institute Foundation
Sex: All
Age: 0+
Code: NCT02061436
Recruiting
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm
for
Coronary Artery Disease
Location: York PA, Browns Mills NJ, New York NY, Roslyn NY,
Sponsor: Kardion Inc
Sex: All
Age: 18 - 70+
Code: NCT06445608
Recruiting
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk